AAAAAA

   
Results: 1-7 |
Results: 7
CYTOGENETIC AND MOLECULAR CHARACTERIZATION OF RANDOM CHROMOSOMAL REARRANGEMENTS ACTIVATING THE DRUG-RESISTANCE GENE, MDR1 P-GLYCOPROTEIN, IN DRUG-SELECTED CELL-LINES AND PATIENTS WITH DRUG-REFRACTORY ALL/
Authors: KNUTSEN T MICKLEY LA RIED T GREEN ED DUMANOIR S SCHROCK E MACVILLE M NING Y ROBEY R POLYMEROPOULOS M TORRES R FOJO T
Citation: T. Knutsen et al., CYTOGENETIC AND MOLECULAR CHARACTERIZATION OF RANDOM CHROMOSOMAL REARRANGEMENTS ACTIVATING THE DRUG-RESISTANCE GENE, MDR1 P-GLYCOPROTEIN, IN DRUG-SELECTED CELL-LINES AND PATIENTS WITH DRUG-REFRACTORY ALL/, Genes, chromosomes & cancer, 23(1), 1998, pp. 44-54
USING THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN TO ASSESS THE EFFECT OF MRP EXPRESSION ON DRUG-SENSITIVITY PROFILES
Authors: ALVAREZ M ROBEY R SANDOR V NISHIYAMA K MATSUMOTO Y PAULL K BATES S FOJO T
Citation: M. Alvarez et al., USING THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN TO ASSESS THE EFFECT OF MRP EXPRESSION ON DRUG-SENSITIVITY PROFILES, Molecular pharmacology, 54(5), 1998, pp. 802-814
REDUCED DRUG ACCUMULATION AND MULTIDRUG-RESISTANCE IN HUMAN BREAST-CANCER CELLS WITHOUT ASSOCIATED P-GLYCOPROTEIN OR MRP OVEREXPRESSION
Authors: LEE JS SCALA S MATSUMOTO Y DICKSTEIN B ROBEY R ZHAN ZR ALTENBERG G BATES SE
Citation: Js. Lee et al., REDUCED DRUG ACCUMULATION AND MULTIDRUG-RESISTANCE IN HUMAN BREAST-CANCER CELLS WITHOUT ASSOCIATED P-GLYCOPROTEIN OR MRP OVEREXPRESSION, Journal of cellular biochemistry, 65(4), 1997, pp. 513-526
CLINICAL REVERSAL OF MULTIDRUG-RESISTANCE
Authors: BATES SE WILSON WH FOJO AT ALVAREZ M ZHAN Z REGIS J ROBEY R HOSE C MONKS A KANG YK CHABNER B
Citation: Se. Bates et al., CLINICAL REVERSAL OF MULTIDRUG-RESISTANCE, Stem cells, 14(1), 1996, pp. 56-63
DRUG-RESISTANT BREAST-CANCER CELLS FREQUENTLY RETAIN EXPRESSION OF A FUNCTIONAL WILD-TYPE P53 PROTEIN
Authors: GUDAS JM NGUYEN H LI T SADZEWICZ L ROBEY R WOSIKOWKSI K COWAN KH
Citation: Jm. Gudas et al., DRUG-RESISTANT BREAST-CANCER CELLS FREQUENTLY RETAIN EXPRESSION OF A FUNCTIONAL WILD-TYPE P53 PROTEIN, Carcinogenesis, 17(7), 1996, pp. 1417-1427
EXPRESSION OF MDR-1 IN REFRACTORY LYMPHOMA - QUANTITATION BY POLYMERASE CHAIN-REACTION AND VALIDATION OF THE ASSAY
Authors: KANG YK ZHAN ZR REGIS J ROBEY R MEADOWS B DICKSTEIN B LEE JS OTSUKI T STETLERSTEVENSON M JAFFE ES SOLOMON D WILSON WH FOJO A BATES SE
Citation: Yk. Kang et al., EXPRESSION OF MDR-1 IN REFRACTORY LYMPHOMA - QUANTITATION BY POLYMERASE CHAIN-REACTION AND VALIDATION OF THE ASSAY, Blood, 86(4), 1995, pp. 1515-1524
EXPRESSION OF MDR-1 IN REFRACTORY LYMPHOMA - QUANTITATION BY POLYMERASE CHAIN-REACTION AND VALIDATION OF THE ASSAY (VOL 86, PG 1515, 1995)
Authors: KANG YK ZHAN ZR REGIS J ALVAREZ M ROBEY R MEADOWS B DICKSTEIN B LEE JS OTSUKI T STETLERSTEVENSON M JAFFE ES SOLOMON D WILSON WH FOJO A BATES SE
Citation: Yk. Kang et al., EXPRESSION OF MDR-1 IN REFRACTORY LYMPHOMA - QUANTITATION BY POLYMERASE CHAIN-REACTION AND VALIDATION OF THE ASSAY (VOL 86, PG 1515, 1995), Blood, 86(12), 1995, pp. 4710-4710
Risultati: 1-7 |